ThomasCharlesNewtonMDFAAP
Pediatrics • Fairfax, VAPediatric Hematology/Oncology
Medical Director- Hematologist/Oncologist; Pediatric Specialists of Virginia; Inova Children’s Hospital; Schar Cancer Institute
Dr. Newton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
765
Fairfax, VA 22031Phone+1 571-472-1717Fax+1 571-472-1718
Education & Training
National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 2005 - 2008
San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 1996 - 1999
Tufts University School of MedicineClass of 1996
University of New HampshireBS, Molecular Biology, Magna Cum Laude, 1988 - 1992
Certifications & Licensure
VA State Medical License 1998 - 2026
DC State Medical License 2020 - 2024
LA State Medical License 2009 - 2021
MS State Medical License Active through 2013- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Hope Award Ulman Cancer Fund, 2017
- Outstanding Service Award Section on Uniformed Services, American Academy of Pediatrics, 2017
- Dean’s Impact Award Uniformed Services University of the Health Sciences, 2016
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsManagement of Hyperhemolysis in β-thalassemia With Multiple Immunosuppressives, Including Complement Blockade.Richard C Zanetti, Lauren M Vasta, Kristen Romanelli, Thomas C Newton
Journal of Pediatric Hematology/oncology. 2021-01-20 - 17 citationsComparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell LinesThomas C. Newton, Karen M. Wolcott, Stephen S. Roberts
Translational Oncology. 2010-08-01 - 7 citationsSubcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand diseaseRajiv Arora, Thomas C. Newton, M.R. Nelson
Annals of Allergy, Asthma & Immunology. 2007-10-01
Grant Support
- Pediatric Oncology Long Term Effects Clinic Transition IniativeJohn P Murtha Cancer Center2014–2018
Professional Memberships
- Fellow
- American Society of Pediatric Hematology/OncologyMember
- Children's Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
